Journal of Renal Nutrition
Volume 14, Issue 3 , Pages 170-179 , July 2004

Renal response to lithogenic and anti-lithogenic supplement challenges in a stone-free population group

  • Sonja Lewandowski, RD, PhD

      Affiliations

    • Research Associate, Department of Chemistry, University of Cape Town, Cape Town, South Africa
    • Corresponding Author InformationAddress reprint requests to Allen Rodgers, PhD, University of Cape Town, Department of Chemistry, Private Bag, Rondebosch 7701, Cape Town, South Africa
    • ,
  • Allen L. Rodgers, PhD

      Affiliations

    • Head of Department of Chemistry and Director of Kidney Stone Research Laboratory, University of Cape Town, Cape Town, South Africa

References 

  1. Ramello A, Vitale C, Marangella M. Epidemiology of nephrolithiasis. J Nephrol. 2000;13:S45–S50
  2. Soucie JM, Thun MJ, Coates RJ, et al.  Demographic and geographic variability of kidney stones in the United States. Kidney Int. 1994;46:893–899
  3. Lewandowski S, Rodgers AL, Schloss I. The influence of a high-oxalate/low-calcium diet on calcium renal stone risk factors in non-stone-forming black and white South African subjects. BJU Int. 2001;87:307–311
  4. Rodgers AL, Lewandowski S. Effects of 5 different diets on urinary risk factors for calcium oxalate kidney stone formation (Evidence of different renal handling mechanisms in different race groups). J Urol. 2002;168:931–936
  5. Curhan GC, Willett WC, Rimm EB, et al.  A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993;328:833–838
  6. Messa P, Marangella M, Paganin L, et al.  Different dietary calcium intake and relative supersaturation of calcium oxalate in the urine of patients forming renal stones. Clin Sci. 1997;93:257–263
  7. Curhan GC, Willett WC, Speizer FE, et al.  Intake of vitamin B6 and C and the risk of kidney stones in women. J Am Soc Nephrol. 1999;10:840–845
  8. Williams H, Smith L. Disorders of oxalate metabolism. Am J Med. 1968;45:715–735
  9. Di Tommaso L, Tolomelli B, Mezzini R, et al.  Renal calcium phosphate and oxalate deposition in prolonged vitamin B6 deficiency (Studies on a rat model of urolithiasis). BJU Int. 2002;89:571–575
  10. Rattan V, Sidhu H, Vaidyanathan S, et al.  Effect of combined supplementation of magnesium oxide and pyridoxine in calcium-oxalate stone formers. Urol Res. 1994;22:161–165
  11. Balcke P, Schmidt P, Zazgornik J, et al.  Pyridoxine therapy in patients with renal calcium oxalate calculi. Proc Eur Dial Transplant Assoc. 1983;20:417–421
  12. Whalley NA, Moraes MFBG, Shar TG, et al.  Lithogenic risk factors in the urine of black and white controls. Br J Urol. 1998;82:785–790
  13. Martins MC, Meyers AA, Whalley NA, et al.  Cystine (A promoter of the growth and aggregation of calcium oxalate crystals in normal undiluted human urine). J Urol. 2002;167:317–321
  14. Resnick MI, Goodman HO, Boyce WH. Heterozygous cystinuria and calcium oxalate urolithiasis. J Urol. 1979;122:52–56
  15. Carpentier PJ, Kurth KH, Blom W, et al.  Heterozygous cystinuria and calcium oxalate urolithiasis. J Urol. 1983;130:302–304
  16. Jaeger P, Portmann L, Saunders A, et al.  Anticystinuric effects of glutamine and of dietary sodium restriction. N Engl J Med. 1986;315:1120–1123
  17. Miyaji K, Nakada F, Ohshiro S. Effect of glutamine on cystine excretion in a patient with cystinuria. N Engl J Med. 1979;301:196–198
  18. Kachmar JF, Grant MA. Proteins and amino acids. In:  Tietz NW editors. Fundamentals of Clinical Chemistry. 1st ed.. London: WB Saunders; 1970;p. 386–388
  19. In:  Langenhoven ML,  Conradie PJ,  Wolmarans P, et al. editor. Medical Research Council Food Quantities Manual. (2nd ed). Cape Town, South Africa: Medical Research Council; 1991;
  20. Chiriboga J. Some properties of an oxalic oxidase purified from barley seedlings. Biochem Biophys Res Comm. 1963;11:277–282
  21. Chrastil J. Spectrophotometric determination of cysteine and cystine in urine. Analyst. 1990;115:1383–1384
  22. Tiselius HG. An improved method for the routine biochemical evaluation of patients with recurrent calcium oxalate stone disease. Clin Chim Acta. 1982;122:409–418
  23. Werness PG, Brown CM, Smith LH. EQUIL 2 (A basic computer program for the calculation of urinary saturation). J Urol. 1985;134:1242–1244
  24. Ryall RL, Hibberd CM, Marshall VR. A method for measuring inhibitory activity in whole urine. Urol Res. 1985;3:285–289
  25. Wolmarans P, Humphreys J, Sayed N, et al.  Foodfinder 2. Cape Town: Nutritional Intervention Unit, South African Medical Research Council; 2001;
  26. Modlin M. The aetiology of renal stones (A new concept arising from studies on a stone-free population). Ann Royal Coll Surg Engl. 1967;40:155–178
  27. Pierratos A, Dharamsi N, Carr LK, et al.  Higher urinary potassium is associated with decreased stone growth after shock wave lithotripsy. J Urol. 2000;164:1486–1489
  28. Martini LA, Cuppari L, Cunha MA, et al.  Potassium and sodium intake and excretion in calcium stone forming patients. J Renal Nutr. 1998;8:127–131
  29. Curhan GC, Willett WC, Speizer FE, et al.  Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Int Med. 1997;126:497–504
  30. Viljoen A, Gericke G. Food habits and food preferences of black South African men in the army (1993–1994). J Fam Eco Cons Sci. 2001;29:100–115
  31. Gill HS, Rose GA. Mild metabolic hyperoxaluria and its response to pyridoxine. Urol Int. 1986;41:393–396
  32. Tolomelli B, Caudarella R, Rizzoli E, et al.  Relationships between some lithogenic factors and vitamin B6—status in idiopathic calcium lithiasis. Int J Vit Nutr Res. 1991;61:304–309
  33. Aunsholt NA, Ahlbom G. The effect of L-glutamine and sodium intake in cystinuric patients. Scand J Urol Nephrol. 1990;24:281–282
  34. Van der Berg CJ, Jones JD, Wilson DM, et al.  Glutamine therapy of cystinuria. Invest Urol. 1980;18:155–157
  35. Joost J, Jarosch E. Glutamine (A new anticystinuric drug?). Eur Urol. 1981;7:363–364
  36. Tschope W, Ritz E. Sulfur-containing amino acids are a major determinant of urinary calcium. Miner Electrolyte Metab. 1985;11:137–139

PII: S1051-2276(04)00067-6

doi: 10.1053/j.jrn.2004.04.007

Journal of Renal Nutrition
Volume 14, Issue 3 , Pages 170-179 , July 2004

Article Tools